Filter posts

BIO’s Start-up Stadium—Springboard to Success

Our fourth and final blog in our series highlighting a few of last year’s Start-up …

Nominate your company to be the Buzz of BIO at #BIO2018!

Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships …

#MakeHistory: Highlighting History | South Korea Goes for Biotech Gold

With the Olympic Games concluding this week in South Korea, the pomp and circumstances in …

ICYMI: Insights from my time with Vicki Sato at BIO CEO & Investor Conference

At this week’s BIO CEO & Investor Conference the idea of saving the “best for …

FDA’s No. 2 Official Sounds Off on Right to Try, Opioid Crisis

During his first State of the Union address two weeks ago, President Donald Trump expressed …

The Art of the Biotech Deal at BIO CEO & Investor Conference

Professionals from all areas of biotechnology convened for the 20th annual BIO CEO & Investor …

#BIOCEO18: Tackling the Opioid Crisis

Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated …

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

#BIOCEO18: Paradigm Shift Creating New Opportunities in China

The past few years have been a time of tremendous change in the world’s second …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …